Multi stakeholders of health and industries perspectives on medicine price transparency initiative in private health care settings in Malaysia.

ABSTRACT:

Introduction

Medicine price transparency initiatives provide public or government on information about the product's prices and the components that may influence the prices, such as volume and product quality. In Malaysia, medicine price transparency has become part of the government's strategies in ensuring adequate, continuous and equitable access to quality, safe, effective and affordable medicines. Since the effect of medicine price transparency depend critically on how prices are presented, this study aims to evaluate the stakeholders' perspective of medicine price transparency practice in the private healthcare system in Malaysia.

Methods

This study was conducted as face-to-face, semi-structured interview. Respondents from private pharmaceutical industries, community p

SUBMITTER: Sufiza Ahmad N 

PROVIDER: S-EPMC7335703 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature